REVIVO™ Dual Summit 1927/1550 Fractional Laser System

The REVIVO Dual Summit 1927/1550 Fractional Laser System is an FDA-cleared dual-wavelength platform combining 1550nm erbium fiber and 1927nm thulium fiber lasers in a single handpiece. It is the only device in this category combining these two wavelengths for fractional non-ablative and superficial ablative skin treatments. **What makes it different:** Unlike single-wavelength systems, the REVIVO Dual Summit allows practitioners to select the 1550nm deep erbium mode, the 1927nm superficial thulium mode, or run both simultaneously. The 1927nm thulium laser opens micro-channels in the skin barrier, enabling enhanced penetration of the 1550nm energy — creating a synergistic treatment effect. It is also the only non-ablative fractional system in this lineup with demonstrated shorter recovery periods than conventional superficial ablative treatments. **Confidence: High** — FDA clearance is explicitly stated; dual-wavelength architecture is confirmed in product data.

The REVIVO Dual Summit's dual-wavelength design enables differentiated protocols for different skin concerns: - **1550nm only (deep treatment)**: Best for deep wrinkles, acne scars, skin tightening, and dermal remodeling. 3–5 sessions, 4–6 week intervals. - **1927nm only (superficial treatment)**: Best for pigmentation, Melasma, tone unevenness, and sun damage. 2–4 sessions, 3–4 week intervals. - **Dual mode (both wavelengths)**: For comprehensive rejuvenation targeting both deep and superficial concerns simultaneously. 3–4 sessions, 4–6 week intervals. **Downtime:** A key differentiator — the REVIVO Dual Summit is designed for **shorter recovery periods than conventional superficial ablative treatments**. Non-ablative 1550nm alone has minimal to no social downtime (mild redness, 1–2 days). The 1927nm thulium has slightly more social downtime (2–4 days of mild erythema). Dual mode typically involves 3–5 days of social downtime. **Confidence: Moderate** — Protocol aligns with established 1550nm/1927nm fractional laser clinical practice. **Flag for procurement: request manufacturer parameter guides for each wavelength and indication.**

The REVIVO Dual Summit 1927/1550 is **FDA cleared** for treating both deep and surface-level skin concerns. **Confidence: High** — FDA clearance is explicitly confirmed in product data. The dual-wavelength 1550nm/1927nm fractional system represents an established FDA-cleared modality used by similar platforms (e.g., Fraxel Dual). **Flag for procurement: verify the specific FDA 510(k) number in the FDA database and confirm clearance covers gynecological/vaginal use if marketed for that indication.**